Eloxx Pharmaceuticals Inc (ELOX)

1.35 -0.11  -7.53% NASDAQ Jul 23, 16:59 USD
View Full Chart
Price Chart
View All ELOX News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
08/06/2021 14:00 EST Earnings Calls Q2 2021 Earnings Call
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/11/2021 Earnings Results Q4 2020 Earnings Results
03/11/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
11/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/06/2020 14:00 EST Earnings Calls Q2 2020 Earnings Call
08/06/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.
  • URL: http://www.eloxxpharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.